McGuireWoods partner Samuel L. Tarry has been named a member of the prestigious International Academy of Trial Lawyers, an honor reserved for lawyers who attain the highest level of advocacy.
The academy limits membership to 500 active trial lawyers from the United States, including prosecutors, plaintiffs’ lawyers, and criminal and civil defense lawyers. Invitations to join the academy are reserved for those who demonstrated excellence throughout their careers in jury trials, bench trials and appellate practice. A comprehensive screening process that includes peer and judicial review is used to identify the most qualified candidates for induction.
Chartered in 1954, the academy seeks to cultivate the science of jurisprudence, promote reforms in the law, facilitate the administration of justice, and elevate the standards of integrity, honor and courtesy in the legal profession.
Tarry co-leads McGuireWoods’ product liability and mass tort practice group and he is a member of the firm’s trial practice steering committee. For nearly three decades, he has represented clients in tort, environmental and public health litigation in state and federal courts across the country. He has won jury trial verdicts in 10 states and successfully managed thousands of cases to resolution. He leads McGuireWoods’ Practice Innovation Office, a team of lawyers and administrative professionals that evaluates, recommends and pilots novel approaches to serving clients.
Tarry co-edited the book “Infectious Disease Litigation: Science, Law & Procedure,” published in February 2021 by the American Bar Association. The book provides practical guidance for handling infectious disease litigation, from COVID-19 pandemic disputes to localized outbreaks that require specialized knowledge.
“The International Academy of Trial Lawyers plays a vital role promoting the highest standards of excellence in our profession,” Tarry said. “I am proud to join the accomplished lawyers in this esteemed organization and look forward to advancing its mission.”